Skip to main content

Find Clinical Trials

Home
Conditions
HIV-1 Infection

Clinical trial condition

HIV-1 Infection

Explore clinical trials studying HIV-1 Infection. Study availability and eligibility vary by location and protocol.

182 public trials 1 recruiting study

Refine in advanced search Browse all conditions

HIV-1 Infection trial results

Completed

Study to Evaluate Effects of Vorinostat and HXTC on Persistent HIV-1 Infection in HIV-Infected Subjects Started on Antiretroviral Therapy (ART)

NCT03212989

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations: University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States

View Trial Details

Completed

Study for Evaluation of the Safety, Pharmacokinetics, and Antiviral Activity of UB-421 Subcutaneous Formulation Administered in HIV-1 Infected Treatment Naive Patients

NCT04620304

Conditions: HIV-1 Infection
Locations: Kaohsiung Veterans General Hospital Kaohsiung City, Taiwan

View Trial Details

Completed

Evaluation of Safety, Tolerability, Pharmacokinetics, and Antiretroviral Activity of Ulonivirine (MK-8507) in Human Immunodeficiency Virus (HIV-1)-Infected Participants (MK-8507-003)

NCT02174159

Conditions: HIV-1 Infection
Locations: Not specified

View Trial Details

Completed

Islatravir (MK-8591) With Doravirine and Lamivudine in Participants Infected With Human Immunodeficiency Virus Type 1 (MK-8591-011)

NCT03272347

Conditions: HIV-1 Infection
Locations: Pueblo Family Physicians ( Site 0119) Phoenix, Arizona, United States

University California / Davis ( Site 0101) Sacramento, California, United States

Whitman Walker Clinic ( Site 0108) Washington D.C., District of Columbia, United States

Orlando Immunology Center (OIC) ( Site 0105) Orlando, Florida, United States

View all 26 locations

View Trial Details

Completed

A Proof-of-concept Trial to Evaluate the Safety and Efficacy of UB-421 Plus Chidamide in Changing HIV Reservoirs

NCT05056974

Conditions: HIV-1 Infection
Locations: Kaohsiung Veterans General Hospital Kaohsiung City, Taiwan, Taiwan

View Trial Details

Completed

ADVANCE Study of DTG + TAF + FTC vs DTG + TDF + FTC and EFV + TDF+FTC in First-line Antiretroviral Therapy

NCT03122262

Conditions: HIV-1 Infection
Locations: Shandukani Research Centre Johannesburg, Gauteng, South Africa

Charlotte Maxeke Johannesburg Academic Hospital Johannesburg, Gauteng, South Africa

Sunnyside Office Park Johannesburg, Gauteng, South Africa

Wits RHI Yeoville Clinic Johannesburg, Gauteng, South Africa

View Trial Details

Completed

Study to Assess Safety and Ability to Induce Immune Responses of HIV-1 Vaccines M3 and M4 Given Alone or in Combination in HIV-infected Adults

NCT03844386

Conditions: HIV-1 Infection, Infections
Locations: University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States

View Trial Details

Completed

The HIV Functional Cure Potential of UB-421 in ART Stabilized HIV-1 Patients

NCT03743376

Conditions: HIV-1 Infection
Locations: Kaohsiung Medical University Chung-Ho Memorial Hospital Kaohsiung City, Taiwan

Kaohsiung Veterans General Hospital Kaohsiung City, Taiwan

Taipei Veterans General Hospital Taipei, Taiwan

View Trial Details

Completed

Study to Assess the Safety and Durability of Viral Control Beyond 24 Weeks of Analytical Treatment Interruption After the Administration of Candidate HIV-1 Vaccines DNA.HTI, MVA.HTI and ChAdOx1.HTI or Placebo in Early Treated HIV-1 Positive Individuals (ATI Extension of AELIX-002 Study)

NCT04385875

Conditions: HIV-1 Infection
Locations: Germans Trias i Pujol Hospital Badalona, Barcelona, Spain

View Trial Details

Completed

EFFICACY AND SAFETY OF A SIMPLIFICATION STRATEGY BASED ON DOLUTEGRAVIR AND DARUNAVIR / COBICISTAT VS OPTIMIZED TREATMENT IN SUPPRESSED HIV-1-INFECTED PATIENTS CARRYING ARCHIVED MULTIDRUG RESISTANCE MUTATIONS

NCT03683524

Conditions: HIV-1 Infection
Locations: Hospital Germans Trias I Pujol Badalona, Barcelona, Spain

View Trial Details